Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

End-of-day quote. End-of-day quote Toronto Stock Exchange - 07/03
11.75 CAD   +1.12%
06/29 CARDIOME PHARMA : SteadyMed and Cardiome Enter into a License Agreem..
06/24 CARDIOME PHARMA : Announces Voting Results
06/16 CARDIOME PHARMA : to Present at JMP Securities Healthcare Conference
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.

Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS, approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults, and AGGRASTAT a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Number of employees : 85 persons.
Sales per Businesses
20132014Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies4.67100.5%33.21100.1% +85.93%
Sales per Regions
20132014Delta
CAD (in Million)%CAD (in Million)%
Rest of World2.7158.2%17.3952.4% +84.44%
Europe1.9642.3%15.8247.7% +87.58%
Managers
NameAgeSinceTitle
William L. Hunter, MD522007President, Chief Executive Officer & Director
William James O'Shea652015Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald, CA-2006Chief Financial Officer
Harold H. Shlevin, PhD652004Independent Director
Richard M. Glickman, PhD552006Lead Independent Director
Mark H. N. Corrigan, MD572015Director
Arthur H. Willms752015Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Shareholders
NameShares%
Westfield Capital Management Co. LP 2,602,963 15.1%
Putnam Investment Management LLC 1,718,096 9.99%
Fidelity Management & Research Co. 1,595,312 9.27%
Turner Investments LP 700,983 4.07%
Clough Capital Partners LP 597,183 3.47%
Rock Springs Capital Management LP 565,000 3.28%
William L. Hunter, MD 560,000 3.25%
Adage Capital Management LP 500,000 2.91%
AlphaOne Investment Services LLC 332,084 1.93%
PointState Capital LP 312,437 1.82%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
BIOGEN INC
CELGENE CORPORATI..
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
WALVAX BIOTECHNOL..
-
MEDY TOX INC
CHONGQING ZHIFEI ..
-
GREEN CROSS CORP
INDIVIOR PLC
CELLDEX THERAPEUT..
AMAG PHARMACEUTIC..
THERAVANCE INC
STAIDSON (BEIJING..
Sector Pharmaceuticals
Cardiome Pharma Corp : Connections
Premier's Technology Council
Trevi Therapeutics, Inc.
Richardson Capital Ltd.
enGene, Inc.
ProStrakan Group Plc
The Vancouver Symphony Foundation
viDA Therapeutics, Inc.
ATDC Seed Capital Fund LLC
Synereca Pharmaceuticals, Inc.
ESSA Pharma Inc
Michael Smith Foundation for Health Research
MedGenesis Therapeutix, Inc.
The Institute of Electrical & Electronics Engineers, Inc.
Kearny Venture Partners
Licensing Executives Society
Vancouver Symphony Orchestra
The American Physiological Society
American Society for Pharmacology & Experimental Therapeutic
British Columbia Lottery Corp.
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2015 People , Fundamentals and Ownership